Exploration of Cerebral Pathophysiology During and After CABG Using CPB
Cerebral Oxidative and Inflammatory Stress and Cerebral Hemodynamics During and After Coronary Artery Bypass Grafting With Use of Cardiopulmonary Bypass
1 other identifier
observational
24
0 countries
N/A
Brief Summary
Purpose: The purpose of this study is to examine cerebral oxidative and inflammatory stress and cerebral hemodynamics during and after coronary artery bypass grafting and correlate with postoperative cognitive function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2011
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 29, 2016
CompletedFirst Posted
Study publicly available on registry
October 21, 2016
CompletedOctober 21, 2016
October 1, 2016
6 months
April 29, 2016
October 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cerebral autoregulation
Flow measurement of middle cerebral artery and measurement of middel arterial pressure
6 hours post operation
Secondary Outcomes (1)
Postoperative cognitive function
One day prior to operation and three days after operation
Study Arms (1)
Ischemic heart disease
Patients admitted for coronary artery bypass grafting with the use of cardiopulmonary bypass
Eligibility Criteria
Patients with ischemic heart disease admitted for coronary artery bypass grafting with the use of cardiopulmonary bypass
You may qualify if:
- Patients with ischemic heart disease admitted for coronary artery bypass grafting with the use of cardiopulmonary bypass
You may not qualify if:
- Cerebrovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Whole blood Serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kirsten Møller, MD PhD DMSc
Rigshospitalet, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
April 29, 2016
First Posted
October 21, 2016
Study Start
July 1, 2011
Primary Completion
January 1, 2012
Study Completion
February 1, 2012
Last Updated
October 21, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share